X-ray-excited photodynamic therapy (X-PDT) employs X-rays as an energy source, overcoming the light penetration limitations of traditional photodynamic therapy (PDT) but is constrained by high-energy radiation and the hypoxic tumor microenvironment. Low-dose X-ray-excited photodynamic therapy and reduction of mitochondrial oxygen consumption can serve as significant breakthroughs in overcoming these barriers. In this study, NaLuF4: Tb/Gd (15%/5%) @NaYF4 nanoparticles adsorbing the photosensitizer MC540 and loaded with α-nitrilotriacetic acid (NEAA) were prepared as low X-ray dose triggered nano-scintillators. The final product obtained was NaLuF4: Tb/Gd (15%/5%) @NaYF4@mSiO2@MC540@NEAA (ScNP-MS@MC540@NEAA) nanocomposites exhibited intense green luminescence. X-PDT generates cytotoxic reactive oxygen species (ROS) with minimal ionizing radiation damage. Simultaneously, NEAA reacts with glutathione (GSH) to generate nitric oxide (NO) or gaseous treatment of damaged mitochondrial respiratory chain to reduce oxygen consumption and alleviate hypoxia, enhancing X-PDT efficacy, and forming a closed-loop treatment. The superoxide ions (·O2-) can rapidly react with NO produced to form the highly cytotoxic reactive nitrogen species (RNS) peroxynitrite anion (ONOO−), which exhibits higher cytotoxicity compared to ROS. Furthermore, GSH scavenges toxic ROS and maintains the physiological function of tumor cells. It can induce cancer cell overoxidation and nitrosative stress. This work describes a low-dose X-ray-triggered X-PDT system with total radiation of 50 mGy, which employs GSH consumption, self-supplied NO, mitochondrial damage alleviation, and hypoxia relief to generate ROS and RNS, forming a closed-loop anti-hypoxia dual-mode system with synergistically enhanced anti-tumor effects, without significant biological side effects. It provides a promising platform for deep-seated tumor X-PDT with considerable application prospects.